Pharmacodynamic equivalence study of two preparations of eye drops, containing dorzolamide in healthy volunteers
Introduction: Dorzolamide 20mg/ml eye drops (dorzolamide hydrochloride (CAS: 120279-96-1)) is a topical carbonic anhydrase inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. The aim: The aim of the present study w...
Main Authors: | Gatchev Emil M., Petrov Andrey D., Hristova Russka W., Demircheva Irenna S., Thyroff-Friesinger Ursula, Richter Wolfram H., Koytchev Rossen K. |
---|---|
Format: | Article |
Language: | English |
Published: |
Srpsko lekarsko drustvo
2016-01-01
|
Series: | Hospital Pharmacology |
Subjects: | |
Online Access: | http://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2016/2334-94921602379G.pdf |
Similar Items
-
Pharmacodynamic approach for proving equivalence of two ophtalmic solutions containing Brimonidine Tartarate 0.2% in healthy volunteers
by: Hristova-Valcheva Ruska, et al.
Published: (2018-01-01) -
Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection
by: Sehnaz Ozcaliskan, et al.
Published: (2015-06-01) -
Comparison of brimonidine-timolol and dorzolamide-timolol in the management of intraocular pressure increase after phacoemulsification
by: Adem Turk, et al.
Published: (2015-10-01) -
Dramatic response to topical dorzolamide in X-linked retinoschisis
by: Rajeswari Thangavel, et al.
Published: (2020-01-01) -
Juvenile X-Linked retinoschisis: Response to topical dorzolamide therapy
by: Krati Gupta, et al.
Published: (2018-01-01)